Let’s Talk Medtech spoke with Dave Hadley, Phd, Senior VP of Research & Development of Cardiac Insight, about the company and the exploding ECG market.
Here's what the medtech industry can expect from the second half of 2021, based on CEO/CFO comments from recent earnings calls.
Emboline has raised $55M in a series D round. The company has developed an embolic protection device designed to provide total embolic protection by capturing and removing all debris from transcatheter procedures.